This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Mar 4;41(5):499-501.

doi: 10.1016/j.molcel.2011.02.017.

PI3K p110β: more tightly controlled or constitutively active?

Affiliations

Affiliation

¹ The Scripps Research Institute, Department of Molecular and Experimental Medicine, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. pkvogt@scripps.edu

PMID: 21362546
DOI: 10.1016/j.molcel.2011.02.017

Free article

Comment

PI3K p110β: more tightly controlled or constitutively active?

Peter K Vogt. Mol Cell. 2011.

Free article

. 2011 Mar 4;41(5):499-501.

doi: 10.1016/j.molcel.2011.02.017.

Author

Affiliation

¹ The Scripps Research Institute, Department of Molecular and Experimental Medicine, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. pkvogt@scripps.edu

PMID: 21362546
DOI: 10.1016/j.molcel.2011.02.017

No abstract available

PubMed Disclaimer

Comment on

Structure of lipid kinase p110β/p85β elucidates an unusual SH2-domain-mediated inhibitory mechanism.
Zhang X, Vadas O, Perisic O, Anderson KE, Clark J, Hawkins PT, Stephens LR, Williams RL. Zhang X, et al. Mol Cell. 2011 Mar 4;41(5):567-78. doi: 10.1016/j.molcel.2011.01.026. Mol Cell. 2011. PMID: 21362552 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science